NCT07140679 2025-09-25Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon CancerEmory UniversityPhase 2 Recruiting40 enrolled
NCT03985891 2020-12-17JSFOLXiangya Hospital of Central South UniversityPhase 1/2 Recruiting40 enrolled